|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 19.04 USD | -0.86% |
|
+5.75% | +52.89% |
| 10-30 | Viatris Begins $36.50 Per Share Cash Offer for Pacira BioSciences | MT |
| 10-28 | US estrogen supply crunch widens as women seek alternatives to scarce patches | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 21.86B | |||||
| 1,263B | |||||
| 658B | |||||
| 521B | |||||
| 391B | |||||
| 369B |
- Stock Market
- Stocks
- VTRS Stock
- Charts Viatris Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
